全文获取类型
收费全文 | 264600篇 |
免费 | 16979篇 |
国内免费 | 1043篇 |
专业分类
耳鼻咽喉 | 2987篇 |
儿科学 | 7246篇 |
妇产科学 | 5395篇 |
基础医学 | 34096篇 |
口腔科学 | 5134篇 |
临床医学 | 26492篇 |
内科学 | 55230篇 |
皮肤病学 | 4086篇 |
神经病学 | 26504篇 |
特种医学 | 11245篇 |
外国民族医学 | 30篇 |
外科学 | 41311篇 |
综合类 | 2700篇 |
现状与发展 | 1篇 |
一般理论 | 183篇 |
预防医学 | 18213篇 |
眼科学 | 6080篇 |
药学 | 17047篇 |
1篇 | |
中国医学 | 341篇 |
肿瘤学 | 18300篇 |
出版年
2023年 | 1328篇 |
2022年 | 2048篇 |
2021年 | 5682篇 |
2020年 | 3286篇 |
2019年 | 5369篇 |
2018年 | 6506篇 |
2017年 | 4797篇 |
2016年 | 5373篇 |
2015年 | 6239篇 |
2014年 | 9040篇 |
2013年 | 12147篇 |
2012年 | 18553篇 |
2011年 | 19377篇 |
2010年 | 10762篇 |
2009年 | 10051篇 |
2008年 | 17096篇 |
2007年 | 18006篇 |
2006年 | 17436篇 |
2005年 | 17342篇 |
2004年 | 16163篇 |
2003年 | 14846篇 |
2002年 | 14190篇 |
2001年 | 3008篇 |
2000年 | 2543篇 |
1999年 | 2936篇 |
1998年 | 3173篇 |
1997年 | 2541篇 |
1996年 | 2189篇 |
1995年 | 1994篇 |
1994年 | 1742篇 |
1993年 | 1709篇 |
1992年 | 1550篇 |
1991年 | 1548篇 |
1990年 | 1376篇 |
1989年 | 1254篇 |
1988年 | 1179篇 |
1987年 | 1119篇 |
1986年 | 1136篇 |
1985年 | 1186篇 |
1984年 | 1250篇 |
1983年 | 1050篇 |
1982年 | 1224篇 |
1981年 | 1149篇 |
1980年 | 999篇 |
1979年 | 805篇 |
1978年 | 763篇 |
1977年 | 673篇 |
1976年 | 618篇 |
1975年 | 530篇 |
1974年 | 564篇 |
排序方式: 共有10000条查询结果,搜索用时 437 毫秒
1.
Kamolz Lars-Peter Kotzbeck Petra Schintler Michael Spendel Stephan 《European Surgery》2022,54(3):163-169
European Surgery - Large skin defects caused by trauma (e.g., burns) or due to other reasons (e.g., tumor-related skin resections) require sufficient skin replacement. The constant improvement of... 相似文献
2.
3.
4.
5.
Mette Nissen Tiina‐Mari Ikheimo Jukka Huttunen Ville Leinonen Henna‐Kaisa Jyrkknen Mikael von und zu Fraunberg 《Neuromodulation》2021,24(1):102-111
ObjectiveSpinal cord stimulation (SCS) is an effective treatment in failed back surgery syndrome (FBSS). We studied the effect of preimplantation opioid use on SCS outcome and the effect of SCS on opioid use during a two-year follow-up period.Materials and methodsThe study cohort included 211 consecutive FBSS patients who underwent an SCS trial from January 1997 to March 2014. Participants were divided into groups, which were as follows: 1) SCS trial only (n = 47), 2) successful SCS (implanted and in use throughout the two-year follow-up period, n = 131), and 3) unsuccessful SCS (implanted but later explanted or revised due to inadequate pain relief, n = 29). Patients who underwent explantation for other reasons (n = 4) were excluded. Opioid purchase data from January 1995 to March 2016 were retrieved from national registries.ResultsHigher preimplantation opioid doses associated with unsuccessful SCS (ROC: AUC = 0.66, p = 0.009), with 35 morphine milligram equivalents (MME)/day as the optimal cutoff value. All opioids were discontinued in 23% of patients with successful SCS, but in none of the patients with unsuccessful SCS (p = 0.004). Strong opioids were discontinued in 39% of patients with successful SCS, but in none of the patients with unsuccessful SCS (p = 0.04). Mean opioid dose escalated from 18 ± 4 MME/day to 36 ± 6 MME/day with successful SCS and from 22 ± 8 MME/day to 82 ± 21 MME/day with unsuccessful SCS (p < 0.001).ConclusionsHigher preimplantation opioid doses were associated with SCS failure, suggesting the need for opioid tapering before implantation. With continuous SCS therapy and no explantation or revision due to inadequate pain relief, 39% of FBSS patients discontinued strong opioids, and 23% discontinued all opioids. This indicates that SCS should be considered before detrimental dose escalation. 相似文献
6.
7.
Victoria L. Parker Matthew C. Winter John A. Tidy Barry W. Hancock Julia E. Palmer Naveed Sarwar Baljeet Kaur Katie McDonald Xianne Aguiar Kamaljit Singh Nick Unsworth Imran Jabbar Allan A. Pacey Robert F. Harrison Michael J. Seckl 《International journal of cancer. Journal international du cancer》2023,152(5):986-997
Gestational trophoblastic neoplasia (GTN) patients are treated according to the eight-variable International Federation of Gynaecology and Obstetrics (FIGO) scoring system, that aims to predict first-line single-agent chemotherapy resistance. FIGO is imperfect with one-third of low-risk patients developing disease resistance to first-line single-agent chemotherapy. We aimed to generate simplified models that improve upon FIGO. Logistic regression (LR) and multilayer perceptron (MLP) modelling (n = 4191) generated six models (M1-6). M1, all eight FIGO variables (scored data); M2, all eight FIGO variables (scored and raw data); M3, nonimaging variables (scored data); M4, nonimaging variables (scored and raw data); M5, imaging variables (scored data); and M6, pretreatment hCG (raw data) + imaging variables (scored data). Performance was compared to FIGO using true and false positive rates, positive and negative predictive values, diagnostic odds ratio, receiver operating characteristic (ROC) curves, Bland-Altman calibration plots, decision curve analysis and contingency tables. M1-6 were calibrated and outperformed FIGO on true positive rate and positive predictive value. Using LR and MLP, M1, M2 and M4 generated small improvements to the ROC curve and decision curve analysis. M3, M5 and M6 matched FIGO or performed less well. Compared to FIGO, most (excluding LR M4 and MLP M5) had significant discordance in patient classification (McNemar's test P < .05); 55-112 undertreated, 46-206 overtreated. Statistical modelling yielded only small gains over FIGO performance, arising through recategorisation of treatment-resistant patients, with a significant proportion of under/overtreatment as the available data have been used a priori to allocate primary chemotherapy. Streamlining FIGO should now be the focus. 相似文献
8.
Hommes Franziska Mohsenpour Amir Kropff Dana Pilgram Lisa Matusall Svenja von Philipsborn Peter Sell Kerstin 《Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz》2022,65(1):96-106
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz - Akteure der öffentlichen Gesundheit (Public Health) tragen wesentlich zu Gesundheitsschutz, -förderung und... 相似文献
9.
10.
Daniel Schar Pawin Padungtod Nguyen Tung Michael OLeary Wantanee Kalpravidh Filip Claes 《Influenza and other respiratory viruses》2019,13(6):618-621
Among the chief limitations in achieving early detection and control of animal‐origin influenza of pandemic potential in high‐risk livestock populations is the existing lag time between sample collection and diagnostic result. Advances in molecular diagnostics are permitting deployment of affordable, rapid, highly sensitive, and specific point‐of‐capture assays, providing opportunities for targeted surveillance driving containment strategies with potentially compelling returns on investment. Interrupting disease transmission at source holds promise of disrupting cycles of animal‐origin influenza incursion to endemicity and limiting impact on animal production, food security, and public health. Adoption of new point‐of‐capture diagnostics should be undertaken in the context of promoting robust veterinary services systems and parallel support for operationalizing pre‐authorized plans and communication strategies that will ensure that the full potential of these new platforms is realized. 相似文献